COMMUNIQUÉS West-GlobeNewswire

VitalHub Reports Continued Positive Earnings in Q2 2019
22/08/2019
TORONTO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and [...]
Arch Scientists Publish Data on the Mechanism of Action and Efficacy of Lead Drug Candidate Metablok in the Prevention of Inflammation and Organ Damage
22/08/2019
TORONTO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that a scientific team led by Dr. Donna Senger, Dr. Stephen Robbins and Dr [...]
Utah social worker David Fowers receives national honor for extensive prevention and treatment work
22/08/2019
Harrisburg, PA, Aug. 22, 2019 (GLOBE NEWSWIRE) -- The National Sexual Violence Resource Center (NSVRC) and the Association for the Treatment of Sexual Abusers (ATSA) are pleased to honor David Fowers with the 2019 Gail- [...]
Tempus Expands Leadership Team With the Appointment of Joel Dudley, PhD, as Senior Vice President of Research
22/08/2019
CHICAGO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announces the appointment of Joel Dudley [...]
ONL Therapeutics Raises $3 Million in a Convertible Note to Advance ONL1204 into First-In-Human Clinical Study
22/08/2019
Lead candidate ONL1204 will advance to Phase I clinical study in retinal detachment in late 2019 ANN ARBOR, Mich., Aug. 22, 2019 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a biopharmaceutical company developing novel [...]
Medifirst Solutions Provides Company Update for Its Oral Mucositis Treatment Studies
22/08/2019
Freehold, NJ, Aug. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared [...]
BioAegis Therapeutics Announces Publication in the Journal of Infectious Diseases: "Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Penicillin-Sensitive and Resistant Pneumococcal Pneumonia"
22/08/2019
MORRISTOWN, N.J., Aug. 22, 2019 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage company developing technology to control inflammation while protecting immune function and vital organs in diseases [...]
Next Green Wave Successfully Completes First Premium Cannabis Harvest
22/08/2019
And Provides Executive Management Update VANCOUVER, British Columbia, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) ("Next Green Wave", “NGW” or the "Company") announces that [...]
AlloSure for Heart Transplant Patients Receives CMS Draft Coverage
22/08/2019
CareDx expands leadership with cfDNA for transplant care BRISBANE, Calif., Aug. 22, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and [...]
Coherus BioSciences Announces New Employment Inducement Grants
22/08/2019
REDWOOD CITY, Calif., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective August 21, 2019, the compensation committee of the company’s board of directors granted 13 [...]
Rafarma’s Agri-Tech Keeping Cannabis Production “High”
22/08/2019
Ljubljana, Slovenia, Aug. 22, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA) - Rafarma is continuing to actively promote its hemp oil products in the European market. Despite the adverse weather [...]
Pressure BioSciences Announces Two More Purchase Orders for its Revolutionary BaroShear K45 Processing System for Manufacturing Water-Soluble CBD
22/08/2019
Company Forecasts All 12 Systems in Current Build Cycle Will Be Sold by September 30, 2019 and Reiterates Previous Guidance for More Than Doubling of Annual Revenue in 2020 SOUTH EASTON, MA, Aug. 22, 2019 (GLOBE [...]
Seelos Therapeutics Announces FDA Acceptance of IND Application for SLS-005 for Mucopolysaccharidosis Type III (Sanfilippo Syndrome)
22/08/2019
Seelos to Proceed with Trial Enrollment and Dosing for Phase IIb/III Trial for Sanfilippo Syndrome Type A and B Patients NEW YORK, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical- [...]
Protalix BioTherapeutics Focuses on Evaluating and Pursuing Alternatives to Maximize Shareholder Value through Refinancing & Strategic Partnerships
22/08/2019
CARMIEL, Israel, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]
CV Sciences, Inc. Announces Distribution Partnership With The Vitamin Shoppe
22/08/2019
Partnership Broadens Distribution of PlusCBD™ Oil Products to More Than 380 Vitamin Shoppe Locations SAN DIEGO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us [...]
Aurora Spine Corporation Reports Record Q2 Revenue; Files Condensed Interim Consolidated Financial Statements for the Three and Six Months Ended June 30, 2019
22/08/2019
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces [...]
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Company’s Milestone Achievements
22/08/2019
NEW YORK, Aug. 22, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing [...]
Golden Leaf Holdings Announces Overwhelming Approval of Extraordinary Resolutions By Debenture Holders
22/08/2019
TORONTO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a pioneer cannabis oil solutions company and dispensary operator built around recognized [...]
Immutep Granted European Patent for Eftilagimod Alpha in Cancer
22/08/2019
SYDNEY, Australia, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]

Pages